✦ LIBER ✦

294 Safety and antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, genotype 1, and liver cirrhosis

✍ Scribed by Heiner Wedemeyer; Andreas Erhardt; Wolff Schmiegel; Holger Hinrichsen; Ricardo Chaves; Chan-Loi Yong; Gerhard Nehmiz; Gerhard Steinman; Boehringer Ingelheim

Book ID: 119530203
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 135 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80337-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

136 Antiviral effect of BILN 2061, a nov

136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1

✍ Markus Reiser; Holger Hinrichsen; Yves Benhamou; Roel Sentjens; Heiner Wedemeyer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

[586] SAFETY, PHARMACOKINETICS AND ANTIV

[586] SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BILB1941, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

✍ A. Erhardt; H. Wedemeyer; Y. Benhamou; C. Moellekens; X. Forns; S. Pol; J.L. Cal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 153 KB

1054 SAFETY, PHARMACOKINETICS AND ANTIVI

1054 SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

✍ Larrey, D.; Benhamou, Y.; Lohse, A.W.; Trepo, C.; Moelleken, C.; Bronowicki, J.- 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB